CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 655383-655662 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"Treatment-related adverse events occurred in 7.1% of epinastine-treated patients (most frequent: eye pain and skin itching, 1.2% each) and 10.3% of levocabastine-treated patients (most frequent: double vision, 3.4%; influenza-like symptoms, 2.3%); most AEs were mild or moderate.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T55089","span":{"begin":0,"end":279},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T55089","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T211","span":{"begin":0,"end":279},"obj":"Sentence"}],"attributes":[{"subj":"T211","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T6053","span":{"begin":216,"end":225},"obj":"Disease"}],"attributes":[{"id":"A6053","pred":"mondo_id","subj":"T6053","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"subj":"T6053","pred":"source","obj":"CORD-19-PD-MONDO"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T3241","span":{"begin":97,"end":105},"obj":"Phenotype"},{"id":"T3242","span":{"begin":110,"end":122},"obj":"Phenotype"},{"id":"T3243","span":{"begin":195,"end":208},"obj":"Phenotype"}],"attributes":[{"id":"A3241","pred":"hp_id","subj":"T3241","obj":"http://purl.obolibrary.org/obo/HP_0200026"},{"id":"A3242","pred":"hp_id","subj":"T3242","obj":"http://purl.obolibrary.org/obo/HP_0000989"},{"id":"A3243","pred":"hp_id","subj":"T3243","obj":"http://purl.obolibrary.org/obo/HP_0000651"},{"subj":"T3241","pred":"source","obj":"CORD-19-PD-HP"},{"subj":"T3242","pred":"source","obj":"CORD-19-PD-HP"},{"subj":"T3243","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1274","span":{"begin":97,"end":100},"obj":"Body_part"},{"id":"T1275","span":{"begin":110,"end":114},"obj":"Body_part"}],"attributes":[{"id":"A1274","pred":"uberon_id","subj":"T1274","obj":"http://purl.obolibrary.org/obo/UBERON_0000970"},{"id":"A1275","pred":"uberon_id","subj":"T1275","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"subj":"T1274","pred":"source","obj":"CORD-19-PD-UBERON"},{"subj":"T1275","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ecd7","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ecbc93"},{"id":"CORD-19-PD-MONDO","color":"#a293ec"},{"id":"CORD-19-PD-HP","color":"#9dec93"},{"id":"CORD-19-PD-UBERON","color":"#ec93b7"}]}]}}